Inside Pharma Influencer Marketing: Missy Voronyak on Vetting, Compliance, and What Comes Next

Most marketers assume pharma influencer marketing is a contradiction in terms. Can creator content really work inside an FDA-regulated industry? In a recent episode of Like, Love, Share by BabbleBoxx, host Sherri Langburt sat down with Missy Voronyak, a parenting-blogger-turned-pharma strategist who has spent more than a decade proving it can. Here are the takeaways worth saving.  

From Parenting Blogger to Pharma Influencer Marketing Specialist

Missy’s path into healthcare influencer marketing is anything but typical. She started as a parenting influencer “back when blogging was cool and innovative,” scoring free LASIK, Disney tickets, and a Macy’s bra-fitting event for her audience.

Her two worlds collided when her son was diagnosed with a long list of food allergies at age one. EpiPens were the only treatment on the market, and pharma came calling. As she put it, that experience taught her “what is it like to be an influencer when pharma comes to you?” Today, that insight shapes how she counsels brands and their compliance teams.

Now running her own agency, she is not shy about the upside of going independent: “I love, love, love being my own boss.” The real win, she says, is “deciding which clients I want to work with and saying no to the ones that I don’t is a type of autonomy that I never had before in agency life.”

Not Every Influencer Is for Sale

The biggest myth Missy wants gone is that you can pay any doctor for a post. “Just because somebody is an influencer doesn’t mean they’re for sale, first of all, right?” Regulated professionals carry high personal standards, and many have employer rules that limit brand work entirely.

That makes vetting the core of the job. Before recommending a single name, she digs in: “I look up what’s called the CMS open payment system. I look up, have these physicians taken money from pharma before? And what was it for?” Her benchmark for fit is deliberately high: “if I ask five influencers, I want all five to say yes.”

For brands that think a campaign is as simple as picking a name off a list, this is the reality check. The screening work no one sees is what makes the campaign land.

Compliance Is the Job, Not the Obstacle

This is where Missy lights up. Pharma content lives or dies by “fair balance,” the FDA principle that risk information has to match the benefits you promote. Her go-to example:

“If you say five good things about Botox and it takes you 30 seconds to say those things, you need to have at least five risks and at least 30 seconds of risk information.”

Plenty of agencies stall out in medical, legal, and regulatory review, then blame the reviewers. Missy flips that posture. Her approach is to “find the yes and let’s partner with those MLR teams and build trust with them so we can get to yes and get it into market.” Brands often hire her precisely because another agency got stuck.

Where Healthcare Influencer Marketing Is Headed

Creator types in this space range from patient advocates and caregivers to lifestyle influencers who happen to live with a condition. But the fastest growth, Missy says, is physician influencers:

“physicians for B2C, direct to consumer. That is where I’m seeing the most growth with pharma companies right now.”

She also points to LinkedIn Thought Leader ads as a frontier, including a psychiatry campaign for a new schizophrenia treatment. She notes that LinkedIn turned the campaign into a case study because of how new the format was for pharma.

Missy is also watching physician collectives like Doc Fluencer MD, where coordinated posting multiplies reach:

“instead of one doctor reaching 1 million people, they’ve got 10 to 20 doctors who have millions of followers and they all talk about it at the same time and they can really make a difference in public health.”

Her advice to brands is to stop playing catch-up and start anticipating: “how can we go where culture is going? And how can we embrace that and be a part of it?”

Regulated Doesn’t Mean Off-Limits

Missy’s career is a standing rebuttal to the idea that regulated industries can’t run influencer marketing. The brands that win here aren’t the ones with the biggest budgets. They’re the ones that vet carefully, treat MLR as a partner instead of a roadblock, and move before the rest of pharma catches up.

Thinking about putting physician or patient creators to work while staying aligned with FTC, FDA, and MLR requirements? BabbleBoxx helps brands build compliant influencer programs from creator vetting through campaign launch. Book a call with our team to map out your next pharma influencer program.